Iveric Bio Inc
(ISEE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,930 | 165,604 | 194,054 | 183,822 | 221,861 |
| Marketable Securities | 155,348 | 155,552 | 104,658 | 109,104 | 74,731 |
| Receivables | N/A | 24,265 | 24,283 | 26,497 | N/A |
| Other current assets | 3,531 | 6 | 30,197 | 10,062 | 4,389 |
| TOTAL | $295,887 | $346,941 | $355,088 | $331,784 | $306,485 |
| Non-Current Assets | |||||
| PPE Net | 3,281 | 3,174 | 3,263 | 3,350 | 3,466 |
| Investments And Advances | 0 | 0 | 27,011 | 63,211 | 95,298 |
| Other Non-Current Assets | 462 | 470 | 492 | 500 | 23,602 |
| TOTAL | $3,743 | $3,644 | $30,766 | $67,061 | $122,366 |
| Total Assets | $299,630 | $350,585 | $385,854 | $398,845 | $428,851 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,032 | 10,389 | 7,769 | 7,287 | 12,018 |
| Accrued Expenses | 47,240 | 40,017 | 25,151 | 21,727 | 18,820 |
| TOTAL | $65,918 | $57,182 | $39,696 | $34,226 | $37,505 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,646 | 6,776 | 6,776 | 5,212 | 6,667 |
| Other Non-Current Liabilities | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 |
| TOTAL | $328,330 | $329,992 | $331,653 | $331,396 | $331,399 |
| Total Liabilities | $394,248 | $387,174 | $371,349 | $365,622 | $368,904 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,808 | 35,698 | 35,593 | 35,371 | 35,252 |
| Common Shares | 36 | 36 | 36 | 35 | 35 |
| Retained earnings | -598,959 | -532,676 | -471,785 | -441,840 | -405,539 |
| Other shareholders' equity | -212 | -159 | -118 | 4 | -473 |
| TOTAL | $-94,618 | $-36,589 | $14,505 | $33,223 | $59,947 |
| Total Liabilities And Equity | $299,630 | $350,585 | $385,854 | $398,845 | $428,851 |